**Specifications Table** {#s0005}
========================

TableSubject areaBiomedicine, BioinformaticsMore specific subject areaHuman Genomics of retinoblastoma and medulloblastoma.Type of dataTables, graphs, chromosome maps and figuresOrganism/cell line/tissueHuman, retinoblastoma and medulloblastoma primary tissuesHow data was acquiredDNA was isolated from snap frozen pediatric tumors (retinoblastoma and medulloblastoma), DNA was pooled and sequenced using an Illumina Genome Analyzer IIX. Expression microarray data was generated with RNA isolated from the corresponding short term primary cultures and analyzed with an in house two channel platform of expression microarrays and using as a reference RNA isolated from *S. cerevisiae* harvested at log phase growth.Data formatRaw sequencing data, analyzed data and mapped dataExperimental factors2 retinoblastoma pools (2 boys and 2 girls each one)1 medulloblastoma pool (4 boys and 1 girl)All patients were naïve to chemotherapy treatment at the moment of the sample collection.Experimental featuresRetinoblastoma and medulloblastoma tissues samples were deep sequenced in 3 pools (2 Rb and 1 Mb). The sequencing data was filtered, mapped using an *in silico* reference and analyzed chromosome by chromosome to evaluate their integrity and to ponder important regions of gains or losses at the chromosomes.ConsentAll tumor tissues were collected under informed written consent from the patients' parents and as part of studies approved by the Scientific and Ethics Review Boards from each participating institution.Data source locationMexico city, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, IMSS and Mexico city, Hospital Infantil de México, SS.Data accessibilityDeposited raw data of the NGS of retinoblastoma and meduloblastoma can be found at: [http://www.ebi.ac.uk/ena/data/view/PRJEB6630.](http://www.ebi.ac.uk/ena/data/view/PRJEB6630){#ir0015}Microarray Data sets are uploaded at GEO-NCBI database in: <http://www.ncbi.nlm.nih.gov/geo/> accession number GSE11488.

**Value of the data** {#s0010}
=====================

•Retinoblastoma tissues naïve to treatment are very rare and scarce and thus difficult to obtain and study.•With the visual graphics presented, the data provides an overview of the retinoblastoma and medulloblastoma genomes structure easy to comprehend, analyze and compare.•This data facilitates the merge of cytogenetic information and vocabulary with next generation sequencing information and vocabulary.•The format of data presentation with the pooling experimental design facilitates navigation through complex data, allowing exploration of recurrent events in an intuitive manner.•Simplicity of these analyses can guide researchers about interesting genomic areas of consistent recurrent losses for further study in these genomes.•The data can help in the design of future analysis like cytogenetics, selecting genes to study by immunohistochemistry, gene hunting etc.•The data can help to easily compare chromosomal changes with other type of tumors.

1. Data {#s0015}
=======

Next generation sequencing was done for retinoblastoma and medulloblastoma samples. These sequences or "reads" were mapped and compared to a human reference genome and low coverage was determined. This comparison allowed the construction of chromosomal maps with positions and association to cytogenetic bands for an overview of the data. An integrity score was used for a panoramic view of the sequencing data. Expression microarray was also done for the same samples and lists of over and under expressed genes are presented related to regions of gains and losses [@bib1].

2. Experimental design {#s0020}
======================

Tumor tissue samples from 8 retinoblastoma patients and from 5 medulloblastoma patients were collected. These 13 samples were deep sequenced as three pools, two for retinoblastoma and one for medulloblastoma. The *in silico* references were generated from a whole human genome sequence GRCh37p5 from the Genome Reference Consortium.

3. Materials and methods {#s0025}
========================

3.1. Patients and DNA extraction {#s0030}
--------------------------------

Eight patients diagnosed with retinoblastoma (Rb) and five with medulloblastoma (Mb) were included. DNA was isolated from snap frozen tumor tissues. Two DNA pools from four Rb patients each were considered biological replicas and one DNA pool containing five Mb patients considered a biological contrast were sequenced. The original and raw data are uploaded at the European Nucleotide Archive and can be found in <http://www.ebi.ac.uk/ena/data/view/PRJEB6630>.

All patients were newly diagnosed and tumor samples were collected at time of surgery, prior to any adjuvant therapy. Tumor tissues were collected under informed written consent from their parents and as part of studies approved by the Scientific and Ethics Review Boards from each participating institution.

3.2. Illumina sequencing {#s0035}
------------------------

Sequencing was performed at the sequencing core facility of the National University of Mexico (UNAM) located at the Biotechnology Institute in Cuernavaca, Mexico using the Illumina Genome Analyzer IIx (Illumina). For sequencing 5 µg of DNA, 1.2 μg DNA from each retinoblastoma per pool, and 1 µg DNA from each meduloblastoma per pool were used to make approximately two hundred base-pair sized libraries using Illumina's Genomic DNA sample prep kit.

3.3. *In silico* genome references {#s0040}
----------------------------------

A reference profile of sequencing data for each sample was obtained using an *in silico* technique. The whole human genome sequence GRCh37p5 was downloaded from the Genome Reference Consortium.

A random sampling of this reference genome was done for the generation of reference sets of reads.

3.4. Reads mapping and symmetric relation treatment {#s0045}
---------------------------------------------------

The treatment applied to both sequencing datasets and *in silico* datasets was the same. After filtering out low quality and low complexity reads, both *in silico* and experimental sets were then mapped to the GRCh37.p5 genome sequence with Bowtie2 [@bib2]. A Perl program was written for extracting the reads that map only once to the Human Genome. For the comparison between the *in silico* reads and *in vitro* reads already mapped, log~2~ ratios values were used.$$\log\ {ratio} = \log_{2}\frac{{Number}\ {of}\ {reads}\ {in}\ {Sample}\ X}{{Number}\ {of}\ {reads}\ {in}\ {Referece}\ X}$$

The log~2~ ratio gives a symmetric relation between two sets of values facilitating the interpretation of the data. For example, a 2 value will be equivalent to a −2, that will correspond to a relation of 4:1 and 1:4 respectively or a fold change of 4.

3.5. ChromDraw {#s0050}
--------------

ChromDraw.exe is a computational program that draws each chromosome and all its cytogenetic bands. This graphic visualization software was written by one of the authors of the present work (Méndez-Tenorio, PhD) with the purpose of facilitating identification of losses and gains in each chromosome by analyzing the comparison between one sample and a reference using the log~2~ ratio value. This software is available upon request.

3.6. Integrity score {#s0055}
--------------------

The integrity score was calculated as a relation between the number of reads in a chromosome and the length of that chromosome, in units of reads/kilobase. The integrity score allow us an overview of losses and gains in all the chromosomes. This score is calculated as follows:$${Score}\ {Chr}i = \frac{{Number}\ {of}\ {reads}\ {in}\ {chromosome}\ i}{{Length}\ {of}\ {chromosome}\ i}\left\lbrack = \right\rbrack\frac{reads}{kB}$$

With this score is possible to explore linearity of sequencing and *in silico* data by plotting the size of each chromosome in millions of bp against the number of reads obtained for each chromosome. Because we found a linear relationship between filtered reads and chromosome size we developed the integrity score. Using this integrity score is possible to determine with low resolution if there is any chromosome with less or more reads compared to its reference. The integrity score was calculated for all the chromosomes in the six data samples, three for the reference samples and three for the pooled tumor samples. [Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"} show the plot for all the references and samples considering or not the Chromosome Y respectively. The *r*^2^ value can be seen in each individual plot. Another figure shows the Integrity Score plotted as bars and a marked difference for chromosome Y is observed in all tumors and reference samples ([Fig. 3](#f0015){ref-type="fig"}).

3.7. Chromosomes analyses by windows {#s0060}
------------------------------------

Each chromosome sequence was divided into fragments of the same length (40 kb) called 'windows'. Mapped reads in each window for both the *in silico* reference and the tumor samples were measured and using ChromDraw data is plotted as log~g~ ratios against the cytogenetic maps ([See Supplemental Maps File](#s0075){ref-type="sec"}) ([Table 1](#t0005){ref-type="table"}).

3.8. Expression microarrays {#s0065}
---------------------------

Expression microarray data was generated at the microarray facility of the National University of Mexico (UNAM) located at the Instituto de Fisiología Celular in Mexico City. Total RNA was obtained using Trizol reagent by Ambion according to manufacturer directions, from short term primary cultures established from enucleated eyes and propagated for seven days in RPMI 15% FBS. In house double channel platform was used and microarrays were printed with a human 50-mer oligo library set "A" from MWG BiotechOligo Gene expression was determined as significant over or under expressed using the Significance Analysis of Microarray (SAM) algorithm from the TM4 suite of programs [@bib3]. A log fold change value larger than 2 or lower than -2 was used for selecting the over and under expresses genes respectively and a false discovery rate of 0.05 [@bib4]. A list with the over and under expressed genes is shown in [Table 2](#t0010){ref-type="table"}.

Appendix A. Supplementary material {#s0075}
==================================

Supplementary material

This work was funded by CONACYT SALUD-2003-C01-83, IMSS 2002/111, 2007-571, and NIH CA167833, CA98180. JT is a recipient of an Exclusivity Scholarship from Fundación IMSS, Mexico. We thank L. Chávez-González, S. Guzmán-León and J.L.Santillán-Torres for technical assistance in the microarray determinations.

Supplementary data associated with this article can be found in the online version at [doi:10.1016/j.dib.2015.12.052](http://dx.doi.org/10.1016/j.dib.2015.12.052){#ir0030}.

![Integrity score for all the samples including ChrY. Each plot corresponds to each one of the samples, in the left the references and in the right the tumors. The points in the plots represent the human chromosomes. Chromosome Y is an outlier indicated by the arrow in all the samples.](gr1){#f0005}

![Integrity score for all the samples not including ChrY. Each plot corresponds to each one of the samples, in the left the references and in the right the tumors. The points in the plots represent the human chromosomes.](gr2){#f0010}

![Integrity score plotted as bars. Each bar corresponds to each chromosome and this figure shows a marked difference for chromosome Y.](gr3){#f0015}

###### 

Shared gross losses between retinoblastoma and medulloblastoma.

Table 1.

  Chromosome   Cytogenetic band   Loss location    \# Genes
  ------------ ------------------ ---------------- ----------
  Chr 5        q13.2              68.5 M--71 M     66
  (2.5 M)                                          
  Chr 6        p22.1              28.4M--33.4 M    407
  p21.33       (5 M)                               
  p21.32                                           
  Chr 17       q21.31             44.1 M--44.6 M   28
  (560 K)                                          
  Chr 19       p13.11             20 M--22.5 M     103
  (2.5 M)                                          
  Chr 19       q13.42             54.5 M--55.5 M   66
  (1.04 M)                                         

###### 

Over and underexpressed genes in retinoblastoma samples.

Table 2.

  **CHR**   **Number of overexpressed genes**   **Symbol**      **log fold change**   **Number of underexpressed genes**   **Symbol**   **log fold change**
  --------- ----------------------------------- --------------- --------------------- ------------------------------------ ------------ ---------------------
  chr1      6                                   CSF3R           2.98                  2                                    LOC376745    −2.59
                                                CDC42BPA        2.55                                                       DDX20        −2.73
                                                FLJ20277        2.33                                                                    
                                                TRIM17          2.32                                                                    
                                                KIAA0663        2.27                                                                    
                                                WARP            2.26                                                                    
  chr2      3                                   ZFHX1B          3.51                  2                                    ANXA4        −2.68
                                                SEMA4F          2.96                                                       TLK1         −2.71
                                                C2orf24         2.14                                                                    
  chr3      5                                   FSTL1           2.83                  0                                                 
                                                SYN2            2.77                                                                    
                                                CCR1            2.28                                                                    
                                                BAP1            2.12                                                                    
                                                ZFYVE20         2.10                                                                    
  chr4      5                                   FGFR3           2.43                  1                                    FABP2        −2.61
                                                MXD4            2.40                                                                    
                                                STK32B          2.35                                                                    
                                                MAD2L1          2.20                                                                    
                                                LIM             2.12                                                                    
  chr5      0                                                                         2                                    SNX2         −2.79
                                                                                                                           PCSK1        −2.86
  chr6      4                                   CUL7            2.75                  6                                    AMD1         −2.13
                                                APOBEC2         2.70                                                       TPMT         −2.33
                                                RXRB            2.52                                                       BF           −2.48
                                                C6orf108        2.27                                                       PGC          −2.53
                                                                                                                           HIST1H1C     −2.74
                                                                                                                           GOPC         −3.38
  chr7      1                                   FLJ20359        2.77                  2                                    ORC5L        −2.76
                                                                                                                           ARP3BETA     −3.53
  chr8      2                                   FLJ14299        2.84                  2                                    IMPA1        −2.70
                                                LY6E            2.49                                                       TNFRSF10A    −2.73
  chr9      2                                   SARDH           2.63                  2                                    C9orf78      −2.54
                                                GTF3C4          2.40                                                       SMARCA2      −3.08
  chr10     3                                   GDF2            2.36                  2                                    SEC23IP      −2.20
                                                CCDC6           2.20                                                       ACADSB       −2.67
                                                LIPA            2.13                                                                    
  chr11     5                                   VEGFB           2.89                  1                                    FLJ22794     −2.71
                                                ZBTB3           2.76                                                                    
                                                TIMM10          2.56                                                                    
                                                DKK3            2.42                                                                    
                                                MTA2            2.24                                                                    
  chr12     7                                   NM_002261       3.30                  3                                    ATP5B        −2.33
                                                NAB2            2.98                                                       ING4         −2.63
                                                DKFZP586A0522   2.85                                                       HCFC2        −2.87
                                                NM_025247       2.50                                                                    
                                                NM_014830       2.47                                                                    
                                                OAS1            2.42                                                                    
                                                OAS1            2.35                                                                    
  chr13     0                                                                         0                                                 
  chr14     1                                   NKX2−8          2.75                  0                                                 
  chr15     3                                   SMAD3           2.99                  0                                                 
                                                B7H3            2.62                                                                    
                                                FOXB1           2.34                                                                    
  chr16     4                                   ALDOA           2.92                  5                                    TRAP1        −2.33
                                                MT3             2.80                                                       MRTF-B       −2.36
                                                SLC12A4         2.75                                                       HMOX2        −2.39
                                                TRADD           2.46                                                       KIAA0174     −2.47
  chr17     7                                   FLJ11164        3.26                  2                                    CCL7         −2.48
                                                HOXB4           3.01                                                       TBCD         −2.61
                                                TOP3A           2.91                                                                    
                                                DKFZp434H2215   2.64                                                                    
                                                FLJ10385        2.62                                                                    
                                                MGC4172         2.54                                                                    
                                                MEOX1           2.24                                                                    
  chr18     0                                                                         0                                                 
  chr19     13                                  SNAPC2          3.07                  4                                    FLJ11535     −2.22
                                                TBXA2R          3.04                                                       POLD1        −2.39
                                                P2RY11          3.00                                                       ASNA1        −3.45
                                                MGC3169         2.86                                                       GAPDS        −4.16
                                                AURKC           2.69                                                                    
                                                CEACAM3         2.56                                                                    
                                                ZNF42           2.37                                                                    
                                                EFNA2           2.36                                                                    
                                                VMD2L1          2.30                                                                    
                                                EPOR            2.27                                                                    
                                                MRPL4           2.26                                                                    
                                                KLF2            2.25                                                                    
                                                IL12RB1         2.08                                                                    
  chr20     2                                   GNRH2           4.23                  0                                                 
                                                GPR8            3.12                                                                    
  chr21     1                                   NDUFV3          2.86                  1                                    CLDN17       −2.90
  chr22     2                                   SUSD2           2.84                  3                                    TOM1         −2.11
                                                XBP1            2.61                                                       PSCD4        −2.24
  chrX      1                                   CTAG1B          2.58                  2                                    HEPH         −2.42
                                                                                                                           DKC1         −2.50
